Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Feed Fumonisins Solution

Inquiry Now
Origin and Types Fumonisin Hazards in Animals Feed Fumonisins Solutions Service Workflow Why Choose Us?

Fumonisins are commonly present in corn and corn-derived products, posing a threat to animal health due to their detrimental effects such as diminishing immune response, causing liver and kidney damage, decreasing weight, and raising mortality rates. BioVenic offers advanced solutions for swiftly and precisely identifying fumonisins in animal feed. Our expertise extends to aiding animal nutrition researchers in formulating additives or employing biological methods to lower the risks associated with fumonisins in animal diets, promoting overall well-being.

Fig. 1 Structures of fumonisins B1, B2, B3, and B4 (Kostić, et al., 2019)Fig. 1 Chemical structures of fumonisins B1, B2, B3, and B41,2

Origin and Types of Fumonisins

Fumonisins are chiefly produced by Fusarium verticillioides (previously known as F. moniliforme), F. proliferatum, F. oxysporum, F. globosum, various other Fusarium species, and Alternaria alternata f. sp. lycopersici. The most prevalent form is FB1, while related metabolites like fumonisin B2 (FB2) and fumonisin B3 (FB3) are typically found in lower quantities. Additionally, the A, C, and P series encompass other recognized fumonisin analogues.

Fumonisin Hazards in Animals

Numerous animal ailments and cancerous conditions, such as leukoencephalomalacia (ELEM), porcine pulmonary edema (PPE), liver toxicity, hepatocarcinomas, kidney damage, and immunosuppression, are commonly linked to fumonisins. Among the fumonisin variants, FB1 stands out as the primary form and principal toxin. The provided table illustrates the varying impacts of fumonisins on distinct animal species.

Table. 1 Impact of fumonisins on animals

Animal Types Effects
Pigs
  • FB1 was identified as the causative agent of porcine pulmonary edema (PPE).
  • Non-lethal pulmonary edema has been reported following longer term, lower dose exposures.
  • Induced a slight reduction of feed intake and body weight in piglets.
  • Altered the absorptive functionality of the intestine.
  • Impaired the integrity of porcine intestinal epithelial cell line.
Horses
  • Synonyms for leukoencephalomalacia (ELEM) include mouldy corn poisoning, blind staggers, corn stalk disease, and circling disease.
  • Caused neurological disease in horses, indicating multifocal CNS involvement.
Chickens
  • Greatly reduced body mass gain and hepatic necrosis, biliary hyperplasia, and thymic cortical atrophy was noted.
  • Increased Sa/So ratios.
  • Abnormal erythrocyte formation and lymphocyte cytotoxic effects.
Fish
  • Fumonisins are toxic for fish and the main target organs are liver and kidney.
  • Fish fed diets containing FB1 at levels of 40 mg/kg or higher had decreased average weight gains.

Feed Fumonisins Solutions

Our feed fumonisin solutions facilitate fumonisin analysis, aiding in the development of feed additives and biological processes to mitigate the harmful impacts of fumonisins in animal feed. Additionally, our services encompass efficacy studies and action mode evaluations utilizing diverse animal models.

  • Fumonisin Analysis Solutions

Our Animal Feed Mycotoxin Analysis services offer feed fumonisin detection services for various sample types and applications. Commonly employed detection methods include enzyme-linked immunosorbent assay (ELISA), lateral flow rapid assay, and high-performance liquid chromatography (HPLC) with fluorescence detection. These assays effectively identify fumonisin contamination in feeds and support researchers in devising strategies for fumonisin detoxification.

  • Feed Additive Development for Fumonisins

To counteract the negative impacts of fumonisins in animal feed, studies have investigated the effects of different feed additives on animal health in fumonisin-exposed animals. Our solution for Feed Additive Development for Fumonisins assesses the efficacy of various types of feed additives and aids in the formulation of highly potent additives to alleviate the harmful effects of fumonisins in animals. Some additives that show promise in reducing fumonisin-related adverse effects include:

  • Fumonisin esterase,
  • Bentonite and enzymatically hydrolyzed yeast,
  • Nanosilicate clay platelets,
  • Boron-fructose.

Biological detoxification methods, such as fermentation and enzymatic processes, provide cost-effective and efficient ways to detoxify fumonisins in animal feed. By examining how microorganisms and enzymes interact with fumonisin-contaminated feed, we assist in identifying and cultivating strains and enzymes that can mitigate the detrimental impacts of fumonisins in animal feed. Some of the beneficial biological detoxifying microorganisms and enzymes include:

  • Microorganisms:
    Lactobacillus plantarum MYS6
    L. rhamnosus strain GG
    L. paracasei BEJ01
    L. pentosus X8
    Pseudomonas sp.
  • Enzymes:
    Carboxylesterase FumD
    Peroxidase
  • Animal Study Solutions for Fumonisins

Through in vitro digestion models, the bioaccessibility of fumonisins in different feed varieties can be assessed. In vivo animal models can then be utilized to explore potential methods for detoxifying animal feed contaminated with fumonisins. At BioVenic, we offer both in vitro and in vivo animal models, as well as animal nutrition and metabolism analysis and omics solutions in animal nutrition and metabolism, facilitating the development of feed fumonisin solutions tailored to different animal species..

Service Workflow of Feed Fumonisins Solution

Fig. 2 Impact of antioxidants on trichothecene-induced oxidative stress (Wu, et al., 2017)

Why Choose Us?

Cutting-Edge Analysis Platforms

We offer advanced fumonisins analysis platforms and assay development technologies to cater to a diverse range of assay requirements efficiently.

Comprehensive Animal Models

Our research includes a broad spectrum of in vivo and in vitro studies utilizing animal models that represent the major species affected by fumonisins.

Research Expertise

Leveraging both internal capabilities and external research collaborations, we focus on developing effective detoxification strategies for fumonisins. We also investigate the effects and mechanisms of fumonisins across various animal species.

The global prevalence of the mycotoxin fumonisins in maize products has emerged as a significant concern. Fumonisins pose health risks to both humans and animals alike. BioVenic's feed fumonisins solutions offer precise and swift detection methods, aiding in the development of efficient detoxification feed additives and biological processes for animals. If you are interested in accessing our feed fumonisins solutions, kindly contact us with your research requirements. We are committed to providing tailored services that align with your specific needs.

References

  1. Image retrieved from Figure 3 "Chemical structures of fumonisins B1, B2, B3, and B4." Kostić et al., 2019, used under [CC BY 4.0]. Without modification.
  2. Kostić, Aleksandar Ž., et al. "Mycotoxins and mycotoxin producing fungi in pollen." Toxins 11.2 (2019): 64.
Inquiry Basket